POSA415 Association of an Adenosine A2A Antagonist Istradefylline on the Treatment Paradigm of Levodopa for Patients with Parkinson’s Disease: Real-World Evidence from a Nationwide Japanese Database over 10 Years (2008-2019)
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.1240
https://www.valueinhealthjournal.com/article/S1098-3015(21)03035-7/fulltext
Title :
POSA415 Association of an Adenosine A2A Antagonist Istradefylline on the Treatment Paradigm of Levodopa for Patients with Parkinson’s Disease: Real-World Evidence from a Nationwide Japanese Database over 10 Years (2008-2019)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)03035-7&doi=10.1016/j.jval.2021.11.1240
First page :
Section Title :
Open access? :
No
Section Order :
10782